www.healthday.com
Nov 5, 2024, 00:34
Steven Artandi: Novel cf-bDNA tests and colorectal cancer screening
Steven Artandi, Director of the Stanford Cancer Institute, shared a paper by Uri Ladabaum et al. on X, adding the following:
“SCI member Uri Ladabaum & others found that 1st gen novel cf-bDNA tests may potentially reduce the incidence and mortality of colorectal cancer compared with no screening, but substantially less profoundly than screening colonoscopy or stool tests.”
Authors: Uri Ladabaum, Ajitha Mannalithara, Robert E. Schoen, Jason A. Dominitz, and David Lieberman.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 12:13
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10
Nov 13, 2024, 10:59